M&A News: Bain Capital Buys 350-Year-Old Japanese Drugs Firm for $3.4 billion
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Axios Login on MSN1d
Bain may bail on Fuji Soft pursuit, after new KKR bid
Bain Capital disclosed that it is considering the "option of withdrawing" its hostile $4.2 billion takeover bid for Japanese ...
BioSpace2d
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
Bain Capital Ventures-backed startup Index raises $2 million to build product management tools
The Australia-based startup gets seed funding to enhance product management tools, facilitating idea tracking and roadmap ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Plastics News7d
Hillenbrand sells majority stake in Milacron to Bain Capital for $287M
Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...
Nikkei Asia5d
Mitsubishi Chemical to sell drug unit to Bain Capital for $3.3bn
TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi ...
Morningstar5d
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
Independent company plans significant investment in innovation, both internal product development and external licensing and acquisitions, supported by Bain Capital investment Bain Capital ...